Cite
MLA Citation
Bianca Weinstock-Guttman et al.. “Ocrelizumab treatment for relapsing-remitting multiple sclerosis after a suboptimal response to previous disease-modifying therapy: A nonrandomized controlled trial.” Multiple sclerosis, vol. 28, 2022, pp. 790–800. http://access.bl.uk/ark:/81055/vdc_100147158190.0x000021